RPA1 and cancer: Whether RECQL5β’ s catalytic activity on a key HR intermediate is important in vivo remains to be formally proven; however, Recql5-deficient mice are cancer-prone and human RECQL5β can displace the major strand recombinase protein Rad51 in an ATP hydrolysis and RPA-dependent manner in vitro [50], suggesting potentially multiple levels of HR regulation.